141 related articles for article (PubMed ID: 9779073)
1. [Positron-emission tomography of the skeletal system using 18FNa: the incidence, pattern of the findings and distribution of benign changes].
Schirrmeister H; Kotzerke J; Rentschler M; Träger H; Fenchel S; Nüssle K; Diederichs CG; Reske SN
Rofo; 1998 Sep; 169(3):310-4. PubMed ID: 9779073
[TBL] [Abstract][Full Text] [Related]
2. Comparison and discrepancy of 18F-2-deoxyglucose positron emission tomography and Tc-99m MDP bone scan to detect bone metastases.
Kao CH; Hsieh JF; Tsai SC; Ho YJ; Yen RF
Anticancer Res; 2000; 20(3B):2189-92. PubMed ID: 10928175
[TBL] [Abstract][Full Text] [Related]
3. [Imaging of the normal skeletal system with 18F Na-PET compared with conventional skeletal scintigraphy using Tc99m-MDP].
Schirrmeister H; Rentschler M; Kotzerke J; Diederichs CG; Reske SN
Rofo; 1998 May; 168(5):451-6. PubMed ID: 9617361
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET.
Schirrmeister H; Guhlmann A; Elsner K; Kotzerke J; Glatting G; Rentschler M; Neumaier B; Träger H; Nüssle K; Reske SN
J Nucl Med; 1999 Oct; 40(10):1623-9. PubMed ID: 10520701
[TBL] [Abstract][Full Text] [Related]
5. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
[TBL] [Abstract][Full Text] [Related]
6. Skeletal PET with 18F-fluoride: applying new technology to an old tracer.
Grant FD; Fahey FH; Packard AB; Davis RT; Alavi A; Treves ST
J Nucl Med; 2008 Jan; 49(1):68-78. PubMed ID: 18077529
[TBL] [Abstract][Full Text] [Related]
7. Anatomical distribution and sclerotic activity of bone metastases from thyroid cancer assessed with F-18 sodium fluoride positron emission tomography.
Schirrmeister H; Buck A; Guhlmann A; Reske SN
Thyroid; 2001 Jul; 11(7):677-83. PubMed ID: 11484897
[TBL] [Abstract][Full Text] [Related]
8. Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT.
Even-Sapir E; Metser U; Flusser G; Zuriel L; Kollender Y; Lerman H; Lievshitz G; Ron I; Mishani E
J Nucl Med; 2004 Feb; 45(2):272-8. PubMed ID: 14960647
[TBL] [Abstract][Full Text] [Related]
9. 18F-Fluoride positron emission tomography and positron emission tomography/computed tomography.
Even-Sapir E; Mishani E; Flusser G; Metser U
Semin Nucl Med; 2007 Nov; 37(6):462-9. PubMed ID: 17920353
[TBL] [Abstract][Full Text] [Related]
10. F-18 NaF PET for detection of bone metastases in lung cancer: accuracy, cost-effectiveness, and impact on patient management.
Hetzel M; Arslandemir C; König HH; Buck AK; Nüssle K; Glatting G; Gabelmann A; Hetzel J; Hombach V; Schirrmeister H
J Bone Miner Res; 2003 Dec; 18(12):2206-14. PubMed ID: 14672356
[TBL] [Abstract][Full Text] [Related]
11. (89)Sr bremsstrahlung single photon emission computed tomography using a gamma camera for bone metastases.
Ota S; Uno M; Kato M; Ishiguro M; Natsume T; Kikukawa K; Tadokoro M; Ichihara T; Toyama H
Ann Nucl Med; 2014 Feb; 28(2):112-9. PubMed ID: 24297387
[TBL] [Abstract][Full Text] [Related]
12. Whole body skeletal imaging with [18F]fluoride ion and PET.
Hoh CK; Hawkins RA; Dahlbom M; Glaspy JA; Seeger LL; Choi Y; Schiepers CW; Huang SC; Satyamurthy N; Barrio JR
J Comput Assist Tomogr; 1993; 17(1):34-41. PubMed ID: 8419436
[TBL] [Abstract][Full Text] [Related]
13. Bone metastases diagnosis possibilities in studies with the use of 18F-NaF and 18F-FDG.
Tarnawska-Pierścińska M; Hołody Ł; Braziewicz J; Królicki L
Nucl Med Rev Cent East Eur; 2011; 14(2):105-8. PubMed ID: 22219151
[TBL] [Abstract][Full Text] [Related]
14.
Langsteger W; Rezaee A; Pirich C; Beheshti M
Semin Nucl Med; 2016 Nov; 46(6):491-501. PubMed ID: 27825429
[No Abstract] [Full Text] [Related]
15. Combined FDG and [F-18]fluoride whole-body PET: a feasible two-in-one approach to cancer imaging?
Hoegerle S; Juengling F; Otte A; Altehoefer C; Moser EA; Nitzsche EU
Radiology; 1998 Oct; 209(1):253-8. PubMed ID: 9769840
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of metastatic bone disease with pentavalent 99Tc(m)-dimercaptosuccinic acid: a comparison with whole-body scanning and 4/24 hour quantitation of vertebral lesions.
Sahin M; Basoglu T; Bernay I; Yapici O; Canbaz F; Yalin T
Nucl Med Commun; 2000 Mar; 21(3):251-8. PubMed ID: 10823327
[TBL] [Abstract][Full Text] [Related]
17. Can we achieve a radionuclide radiation dose equal to or less than that of 99mTc-hydroxymethane diphosphonate bone scintigraphy with a low-dose 18F-sodium fluoride time-of-flight PET of diagnostic quality?
Ohnona J; Michaud L; Balogova S; Paycha F; Nataf V; Chauchat P; Talbot JN; Kerrou K
Nucl Med Commun; 2013 May; 34(5):417-25. PubMed ID: 23470463
[TBL] [Abstract][Full Text] [Related]
18. Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions.
Cook GJ; Houston S; Rubens R; Maisey MN; Fogelman I
J Clin Oncol; 1998 Oct; 16(10):3375-9. PubMed ID: 9779715
[TBL] [Abstract][Full Text] [Related]
19. Skeletal metastases from breast cancer: uptake of 18F-fluoride measured with positron emission tomography in correlation with CT.
Petrén-Mallmin M; Andréasson I; Ljunggren O; Ahlström H; Bergh J; Antoni G; Långström B; Bergström M
Skeletal Radiol; 1998 Feb; 27(2):72-6. PubMed ID: 9526771
[TBL] [Abstract][Full Text] [Related]
20. [Combining CT and scintigraphy: SPECT-CT and PET-CT].
Vöö S; van Dongen TM; Waterval JJ; Willems P; Mottaghy F; Brans B
Ned Tijdschr Geneeskd; 2011; 155(36):A2792. PubMed ID: 21914229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]